Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.01 USD | -4.65% | +27.54% | +809.45% |
Jun. 05 | GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients | CI |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Business Summary
Number of employees: 1,000
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
GeneDx
96.0
%
| 122 | 52.1 % | 194 | 96.0 % | +59.02% |
Legacy Sema4
4.0
%
| 112 | 47.9 % | 8 | 4.0 % | -92.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 235 | 100.0 % | 203 | 100.0 % | -13.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Murali Mani
CMP | Compliance Officer | - | 19-12-31 |
Eli Casdin
BRD | Director/Board Member | 51 | 20-06-30 |
Melanie Duquette
PRN | Corporate Officer/Principal | - | 23-09-10 |
Devin Schaffer
LAW | General Counsel | - | 23-04-23 |
Kareem Saad
PRN | Corporate Officer/Principal | 45 | 21-07-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Eli Casdin
BRD | Director/Board Member | 51 | 20-06-30 |
Chief Executive Officer | 48 | 22-04-28 | |
Jason Ryan
CHM | Chairman | 49 | 21-07-21 |
Emily Leproust
BRD | Director/Board Member | 51 | 20-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,150,866 | 17,963,500 ( 68.69 %) | 0 | 68.69 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+809.45% | 654M | |
-22.13% | 7.9B | |
+76.16% | 4.53B | |
+9.32% | 2.78B | |
-50.41% | 1.99B | |
-19.59% | 1.66B | |
-20.07% | 1.49B | |
+19.31% | 1.23B | |
-45.78% | 1.1B | |
+21.21% | 996M |
- Stock Market
- Equities
- WGS Stock
- Company GeneDx Holdings Corp.